Do Mast Cells on a Colon Biopsy Explain Diarrhea? What 3,508 Reports Found
In 3,508 colon biopsy reports, diarrhea was no more common at higher mast cell counts, and a count per field isn't part of the MCAS criteria.

Photo: Marc Pell / Unsplash
You had the colonoscopy, the biopsy report mentioned increased mast cells, and now you're wondering whether those cells are the reason for your diarrhea. That's a reasonable chain of thought. Back in 2006, a study found extra mast cells in 33 of 47 people, about 70%, whose chronic diarrhea had no other explanation. In October 2026, researchers in Vienna and Houston published a check of that idea in 3,508 colon biopsy reports. Turns out, diarrhea was no more common at higher mast cell counts than at normal ones.
So the mast cell count on your report might not explain your diarrhea. A count per field also isn't part of either main set of MCAS (mast cell activation syndrome) criteria, known as consensus-1 and consensus-2. The way I look at it, mast cells are normal residents of the gut lining, and the finding becomes abnormal when they occur in clumps. This post goes through the cutoff's history, the new study, and what the criteria require.
Where does the "more than 20" cutoff on your report come from?
Your report might give mast cells as a number, or it might use a word like "increased." Mast cells are immune cells that release chemical messengers called mediators. Pathologists count them under the microscope one high-power field (hpf) at a time, and one hpf is a single circle of tissue seen at high magnification.
The usual cutoff goes back to a 2006 study by Jakate and colleagues at Rush University Medical Center in Chicago. They stained colon or duodenal biopsies for tryptase, an enzyme that mast cells store and release. The duodenum is the start of the small intestine. In 50 control subjects the average was 13.3 mast cells per hpf, give or take 3.5. So some mast cells on a biopsy are expected. The team counted anything above 20, well past that average, as increased. Of 47 people picked because nothing else explained their chronic diarrhea, 33 were above 20, about 70%. The study's abstract, its short published summary, reports that medicines acting on mast cell mediators controlled symptoms in 22 of those 33, about two in three, and it describes no untreated comparison group. The team called the pattern mastocytic enterocolitis. Checking whether people with higher counts have diarrhea more often took a much larger set of reports.
Did diarrhea become more common as mast cell counts went up?
Langreiter, Genta, and Schreiner analyzed a large US pathology database of colonoscopies done from January 2009 to December 2023. Their main question was whether people with higher mast cell counts had diarrhea more often than people with normal counts. Once they set aside screening colonoscopies and repeat procedures, 2,059,147 colonoscopies remained, a little over 2 million. Pathologists evaluated mast cells in 3,508 reports. That's 0.17%, fewer than 2 in every 1,000, so a mast cell count is a rare addition to a colon biopsy report. In 1,167 of the 3,508, about a third, the report described increased mast cells or gave a count above 20 per hpf.
Diarrhea was present in 58.3% of people with fewer than 20 mast cells per hpf, slightly more than half. At 20 to 39, 40 to 59, and 60 to 98 per hpf it was 54.1%, 54.7%, and 50.0%, still about half each time. In the top band, 99 or more, it was 33.3%, about one in three. So none of the higher bands had more diarrhea than the lowest one. The researchers concluded that these data don't show a relationship between diarrhea and elevated mast cells in the colon lining, a conclusion about diarrhea alone, since the abstract gives no band sizes, tryptase levels or MCAS diagnoses. They suggested that adding a mast cell count to colon biopsies taken for common gut complaints may not be warranted. Diarrhea is one symptom, though. An MCAS diagnosis depends on what the criteria require.
What do the MCAS criteria require, if not a count?
The authors of a 2020 paper labeled the two main sets of MCAS diagnostic criteria consensus-1 and consensus-2. If two sets of criteria feel like a lot to keep straight, how consensus-1 and consensus-2 differ and why the expert groups disagree goes through both in more detail than there's room for here.
Valent and colleagues published the consensus-1 criteria in 2012. The criteria require typical symptoms, a substantial short-lived rise in serum tryptase or a rise in another mast cell mediator such as histamine, and symptoms that respond to medicines that reduce the production or activity of mast cell mediators. The list in the abstract has no biopsy count. If you've had a tryptase drawn, what tryptase and urine mediator tests measure and when to time a flare draw covers the second criterion in more depth, and the MCAS hub puts the testing and criteria posts in one place. The authors of consensus-2 did include a biopsy finding, and the one they chose is about how the mast cells are arranged.
Clumped mast cells on a biopsy can count toward an MCAS diagnosis
The original consensus-2 proposal came from Molderings, Afrin, and colleagues in 2011. One of its two major criteria is multifocal or disseminated dense infiltrates of mast cells, meaning dense clusters in more than one spot or spread through the tissue. Those can be in a bone marrow biopsy or in another organ such as a gut biopsy, with the tissue stained for tryptase and for surface markers such as CD25. The other major criterion is a typical pattern of symptoms from mast cell mediators. The paper's symptom table covers nearly every organ system, from belly pain and diarrhea to flushing and hives. According to the paper's table, the diagnosis is made with both major criteria, or with the symptom criterion plus at least one minor one, such as a raised mediator level in a blood or urine test.
Put another way, the tissue criterion is about density. It describes mast cells packed together in one area. The WHO criterion for systemic mastocytosis, listed beside it in the same table, is dense clusters of more than 15 mast cells.
When mast cells are present on a biopsy in large numbers and in clumps, that's when I think we may also need to work up for mastocytosis.
Mastocytosis is a condition where one abnormal line of mast cells keeps copying itself. Doctors call that kind of copying clonal, meaning too many copies of one cell type. We want to rule a clonal process out if we're seeing too many mast cells in one place, because that many isn't normal for mast cells. Molderings's group cited findings suggesting that mast cell clusters, one of the features pathologists use to diagnose systemic mastocytosis, are causally related to and specific for a change in KIT, the gene for a protein that helps regulate mast cell activity. So clusters on a biopsy are one reason to look for a clonal process.
If your report says "increased mast cells," that finding might be one clue in your workup. Your clinician still has to weigh it next to your symptoms and labs before anyone can say mast cells explain your diarrhea. That said, your count can also be normal while MCAS is still possible, since under consensus-2 the symptom criterion plus a raised mediator test is enough.
Your biopsy report, and the tissue the lab may still have
Because dense clusters on a gut biopsy count toward consensus-2, the tissue you've already had taken might still be part of your workup. As far as I know, some labs keep biopsy tissue for years. A pathologist can stain a stored endoscopy or colonoscopy sample for mast cells and look for clusters, but the lab doesn't usually run that stain on a routine biopsy, so it has to be requested. If yours was done within the last few years, it's a good idea to consider asking your doctor to call the lab and request a tissue stain for mast cells.
Your clinician can help you sort out whether a mast cell finding fits MCAS. These are questions you could start with when you talk to whoever ordered the biopsy.
- Was my result a number per high-power field, or a description like "increased"?
- Did the pathologist see clusters, and were the cells stained for CD25?
- Have other causes of chronic diarrhea been checked, such as celiac disease, inflammatory bowel disease, and microscopic colitis?
- Do my symptoms outside the gut, and any mediator labs, fit an MCAS pattern?
- If my count was normal, is MCAS still being considered, and what else could explain my symptoms?
Since the tissue from your colonoscopy might still be at the lab, your report and that stored sample give you something to work from between appointments. If your biopsy report has you looking into MCAS, I put the first things to know about the diagnosis into a free guide, MCAS: What You Need to Know First.
FAQ
What is a normal mast cell count in the colon?
The usual cutoff comes from a 2006 study, where 50 control subjects averaged 13.3 mast cells per high-power field and the researchers counted more than 20 as increased. Reports can give mast cells as a number or as a word like "increased," and asking how your result was measured can clear up which one you have.
What is mastocytic enterocolitis?
Mastocytic enterocolitis is the name Jakate and colleagues gave in 2006 to chronic, unexplained diarrhea with more than 20 mast cells per high-power field on a colon or duodenal biopsy. They found the extra mast cells with a tryptase stain, even when the biopsy could look unremarkable on the routine stain. A 2026 study of 3,508 colon biopsy reports found diarrhea was no more common at higher counts, so a high count might not explain diarrhea on its own.
Can a colon biopsy diagnose MCAS?
Not by itself. MCAS has two main sets of diagnostic criteria, consensus-1 from 2012 and consensus-2 from 2011, labeled that way in a 2020 paper. The published summary of consensus-1 lists symptoms, a mediator rise such as tryptase, and response to treatment, with no biopsy count. Consensus-2 includes dense clusters of mast cells on a biopsy as one major criterion, next to the typical symptom pattern.
Does a normal biopsy rule out MCAS?
No. Under consensus-2, one of the two main sets of MCAS diagnostic criteria, the typical symptom pattern plus a raised mediator test is enough, with no biopsy needed. The published summary of consensus-1, the other main set, lists symptoms, a mediator rise and response to treatment, with no biopsy count. Your clinician can weigh a normal count alongside everything else.
Can an old biopsy be checked for mast cells?
It can be, if the lab still has the tissue. Some labs keep biopsy tissue for years, and a pathologist can stain a stored sample for mast cells and look for clusters, as an extra request, because the lab doesn't usually run that stain on a routine biopsy. Clusters of mast cells count toward the consensus-2 criteria for MCAS, and your clinician still weighs the result next to your symptoms and other tests.
References
- 1.
- 2.
- 3.
- 4.
- 5.




